Ranibizumab in Diabetic Vitrectomy
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Ranibizumab in Diabetic Vitrectomy is a clinical trial[1].
Key Facts
- Ranibizumab in Diabetic Vitrectomy is in the country of United Kingdom[2].
- Ranibizumab in Diabetic Vitrectomy's instance of is recorded as clinical trial[3].
- Ranibizumab in Diabetic Vitrectomy's start time is recorded as +2011-05-31T00:00:00Z[4].
- Ranibizumab in Diabetic Vitrectomy's end time is recorded as +2013-03-31T00:00:00Z[5].
- Ranibizumab in Diabetic Vitrectomy's sponsor is recorded as Moorfields Eye Hospital[6].
- Ranibizumab in Diabetic Vitrectomy's main subject is recorded as VITREORETINAL SURGERY WITH SILICONE OIL TAMPONADE IN PRIMARY UNCOMPLICATED RHEGMATOGENOUS RETINAL DETACHMENT: Clinical Outcomes and Complications[7].
- Ranibizumab in Diabetic Vitrectomy's main subject is recorded as retinal neovascularization[8].
- Ranibizumab in Diabetic Vitrectomy's main subject is recorded as diabetic retinopathy[9].
- Ranibizumab in Diabetic Vitrectomy's number of participants is recorded as {'unit': '1', 'amount': '+30'}[10].
- Ranibizumab in Diabetic Vitrectomy's title is recorded as A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study[11].
- Ranibizumab in Diabetic Vitrectomy's short name is recorded as RaDiVit[12].
- Ranibizumab in Diabetic Vitrectomy's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[13].
- Ranibizumab in Diabetic Vitrectomy's ClinicalTrials.gov ID is recorded as NCT01306981[14].
- Ranibizumab in Diabetic Vitrectomy's research intervention is recorded as ranibizumab[15].
- Ranibizumab in Diabetic Vitrectomy's clinical trial phase is recorded as phase IV clinical trial[16].
- Ranibizumab in Diabetic Vitrectomy's research site is recorded as Moorfields Eye Hospital[17].
- Ranibizumab in Diabetic Vitrectomy's study type is recorded as interventional study[18].